Haemonetics (HAE) PT Lowered to $86 at Needham & Company

May 13, 2021 1:03 PM

Needham & Company analyst Mike Matson lowered the price target on Haemonetics (NYSE: HAE) to $86.00 (from $108.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found